IGF-1 Dosing Protocol: Somatomedin C Research Guide
Also known as: IGF-1, Somatomedin C, Des(1-3) IGF-1 Localized Growth Factor
Studied in published research — not a medical recommendation. Primary protocol (Growth/Recovery Protocol): 40-80 mcg, Daily or twice daily.
Daily or twice daily
Research-reported range (no primary dosing study). FDA approved for growth disorders; research use in other areas
Subcutaneous injection
Published peer-reviewed research & clinical protocols
No verified human half-life on file for this compound
A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.
All U-100: 100 units = 1 mL. 125 doses in the vial at the low end (62 doses at the high end).
Save IGF-1 DES (1-3) to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.
IGF-1 DES (1-3) supplier & $/mg comparison.
At a Glance · 2026 FDA / 503A / WADA / Evidence Profile
What is a Peptide?
A short chain of amino acids (2-50) linked by peptide bonds. Smaller than proteins. Your body produces thousands of peptides naturally as signaling molecules that regulate everything from appetite to healing. Therapeutic peptides mimic or enhance these natural signals.
EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. IGF-1 DES (1-3) is not FDA approved for human use (unless specified above). This information does not constitute medical advice.
Overview
IGF-1 is a hormone similar in structure to insulin that plays a critical role in growth and development. It is produced primarily in the liver in response to growth hormone.
Mechanisms of Action
- Activates IGF-1 receptor (tyrosine kinase)
- Promotes cell growth, proliferation, and survival
- Enhances protein synthesis and muscle growth
- Supports bone growth and mineralization
Research Protocols
Summaries of published research. For educational purposes only.
| Protocol Name | Source | Dose | Frequency | Duration | Route | Evidence | Link | Save |
|---|---|---|---|---|---|---|---|---|
| Growth/Recovery Protocol | reported protocol | 40-80 mcg | Daily or twice daily | 4-8 weeks | Subcutaneous injection | human | — |
GH / IGF-1 & Glycemic Sensitivity Biomarker Panel (IGF-1 DES (1-3))
Growth hormone secretagogues and somatomedin analogs directly elevate hepatic IGF-1 and can shift fasting insulin sensitivity via GH counter-regulatory signaling.
Serum IGF-1 (LC/MS) + Z-Score
Day 0 + Wk 6–8Why track at baseline: Establishes baseline somatotropic output before pituitary or local IGF-1R stimulation.
Week 6–8 check: Confirm physiological upper-quartile elevation (typically +30% to +80% above baseline) without supraphysiological overshoot (>300 ng/mL).
Fasting Insulin & HOMA-IR
Day 0 + Wk 6–8Why track at baseline: Pituitary GH pulses promote free fatty acid mobilization, which can transiently reduce peripheral insulin sensitivity.
Week 6–8 check: Keep Fasting Insulin <6–8 uIU/mL; if elevated, enforce strict 2–3 hr pre-bed fasting before GH secretagogue administration.
HbA1c & Fasting Plasma Glucose
Day 0 + Wk 6–8Why track at baseline: Screens for subclinical prediabetes prior to growth-factor or secretagogue exposure.
Week 6–8 check: Verify stable 90-day glycemic control (HbA1c <5.4% optimal) at Week 6–8.
hs-CRP, Prolactin & CMP
Day 0 + Wk 6–8Why track at baseline: Checks systemic inflammation, pituitary selectivity (no off-target prolactin/cortisol rise), and hepatic/renal clearance.
Week 6–8 check: Confirm Ipamorelin/CJC/Tesamorelin selectivity with unchanged Prolactin and normal liver transaminases.
Community Outcomes
Community Data Coming Soon
Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!
Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.
Important Warnings
- •May promote tumor growth - contraindicated with active cancer
- •Can cause hypoglycemia
- •Joint pain and fluid retention common
- •Requires medical supervision
Where to get IGF-1 DES (1-3), baseline labs & clinician oversight.
Ascension Peptides (US Vials)
MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.
SwissChems & Limitless Biotech
Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).
Superpower Labs & 503A Telehealth
Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.
Where to buy IGF-1 DES (1-3): best verified price
Prices checked Nov 11, 2026 · sorted by $/mg · RUO
- 1. Swift Peptides — $84.99/mg (1mg vial, $84.99)
- 2. Elite Research USA — $85.00/mg (1mg vial, $85.00)
- 3. Polaris Peptides — $85.00/mg (1mg vial, $85.00)
Where is the cheapest place to buy IGF-1 DES (1-3)?
As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Swift Peptides at $84.99/mg (1mg vial, $84.99). We compared 6 US suppliers with live, checked prices.
How much does IGF-1 DES (1-3) cost per mg?
Verified US domestic prices currently range from $84.99/mg to $150.00/mg depending on supplier and vial size. Larger vials usually lower the $/mg.
How are these prices verified?
Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.
Is IGF-1 DES (1-3) approved for human use?
Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.
All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet
Peptide Reconstitution & U-100 Syringe Cheat Sheet
Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.
Related Peptides
More hormonal peptides
CJC-1295 (No DAC / Mod GRF 1-29)
CJC-1295 is a synthetic analog of growth hormone-releasing h...
Ipamorelin
Ipamorelin is a growth hormone secretagogue that selectively...
GHRP-2 (Pralmorelin)
GHRP-2 is a synthetic growth hormone-releasing peptide that ...
GHRP-6
GHRP-6 is a first-generation growth hormone-releasing peptid...
Hexarelin
Hexarelin is a synthetic growth hormone-releasing peptide (G...
Vendor vs vendor: price per mg
Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.
- Ascension vs SwissChems (3 shared compounds)
- Elite vs SwissChems (3 shared compounds)
- Elite vs Ascension (26 shared compounds)
- Protide vs SwissChems (3 shared compounds)
- Protide vs Ascension (6 shared compounds)
- Ameano vs SwissChems (3 shared compounds)
- Ameano vs Ascension (4 shared compounds)
- Swift vs Ascension (23 shared compounds)
- BioLongevity vs Ascension (16 shared compounds)
- Peptyes vs SwissChems (3 shared compounds)
- Peptyes vs Elite (20 shared compounds)
- Peptyes vs Swift (17 shared compounds)
- Peptyes vs Pure (17 shared compounds)
- Peptyes vs Ascension (20 shared compounds)
Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →
Common questions
How many peptides are in the database?
100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.
Where can I compare peptide prices?
Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.